Us Bancorp \De\ Rigel Pharmaceuticals Inc Transaction History

Us Bancorp \De\

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$1.12 - $1.57 $14,210 - $19,920	-12,688 Reduced 26.94%	34,403 $50,000
Q4 2023 Feb 09, 2024	BUY	$0.72 - $1.56 $33,905 - $73,461	47,091 New	47,091 $68,000
Q4 2021 Feb 11, 2022	SELL	$2.36 - $3.57 $2,341 - $3,541	-992 Closed	0 $0
Q4 2020 Feb 04, 2021	BUY	$2.35 - $3.74 $2,331 - $3,710	992 New	992 $3,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.